$2.25
-1.38-38.02%
Last update: Oct 23, 7:29 PM
Macrogenics Inc (MGNX) Stock Price, Quote, News & History
MGNXNASDAQ
MacroGenics sees stock decline after FDA places partial clinical hold on Phase 2 LINNET study due to safety concerns.
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Other companies in Macrogenics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Macrogenics has a consensus price target of $8.00.
The stock price for Macrogenics (NASDAQ: MGNX) is $2.3248 last updated October 23, 2026 at 7:29 PM EDT.
There are no upcoming dividends for Macrogenics.
Macrogenics does not have any upcoming earnings scheduled.
There is no upcoming split for Macrogenics.
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug...
